Hao Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hao Sun has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Dan Wang
Pharmacy Department, Zhejiang Hospital, Hangzhou, 310030, China
4 shared publicationsYi Gao
Pharmacy Department, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China
3 shared publications- Zheng Xiang
Shenyang Key Laboratory for Causes and Drug Discovery of Chronic Diseases, Liaoning University, Shenyang 110036, PR China
3 shared publications Dahui Chen
School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China
2 shared publicationsFan Li
Department of Pharmacy, Women\'s Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
2 shared publicationsMengjin Xu
Department of Pharmacy, Women\\\'s Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
2 shared publications
Latest Publications
- Open Access
- 16 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (3) , e47086
Dissecting the relationship between hypertensive disorders of pregnancy and branched-chain amino acids: An integrated investigation combining Mendelian randomization, transcriptomics, and machine learning
Empirical investigations have identified associations between elevated branched-chain amino acids (BCAAs) levels and an increased incidence of hypertensive disorders of pregnancy (HDP). The aim of this study is to rigorously explore the causal linkage between BCAAs concentrations and the risk of developing HDP. A bidirectional Mendelian randomization (MR) analysis was conducted to ascertain the causal relationship between BCAAs levels and the risk of HDP. Instrumental genetic variables derived from the genome-wide association studies of serum BCAAs levels – encompassing total BCAAs, leucine, isoleucine and valine from the UK Biobank, and HDP data (16,417 cases and 213,893 controls) from the FinnGen consortium – were utilized. We conducted inverse-variance weighted, MR-Egger, simple mode, and weighted MR estimates. To assess the heterogeneity and potential presence of horizontal pleiotropy among the instrumental variables, Cochran Q statistic and the MR-Egger intercept were employed. Simultaneously, transcriptomic data were utilized in conjunction with machine learning to identify key genes through which BCAAs influence HDP. Single-cell techniques were employed to analyze the major cell populations. The forward MR analysis indicated a significant positive correlation between the levels of total BCAAs (OR: 1.300, 95% CI: 1.117–1.462; P < .0001), leucine (OR: 1.096, 95% CI: 1.123–1.505; P < .0001), and valine (OR: 1.299, 95% CI: 1.141–1.478; P < .0001) with the risk of HDP. Isoleucine levels (OR: 1.266, 95% CI: 1.054–1.521; P = .012) demonstrated a positive association with HDP risk that did not reach statistical significance after Bonferroni correction. The reverse analysis revealed no causal effect of HDP on the levels of total BCAAs (OR: 0.992, 95% CI: 0.967–1.018; P = .543), leucine (OR: 1.005, 95% CI: 0.973–1.039; P = .750), isoleucine (OR: 1.000, 95% CI: 0.974–1.026; P = .973), and valine (OR: 0.988, 95% CI: 0.962–1.014; P = .354). Transcriptomic analysis identified MCCC2 and BCAT2 as key genes through which BCAAs affect the occurrence of HDP, and these genes are predominantly expressed in endothelial cells. We provide robust evidence Our findings suggest that HDP was associated with an increased level of BCAAs, and the effects may be related to the expression levels of MCCC2 and BCAT2 in endothelial cells.
- 16 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (3) , e47086
Open AccessDissecting the relationship between hypertensive disorders of pregnancy and branched-chain amino acids: An integrated investigation combining Mendelian randomization, transcriptomics, and machine learning
Empirical investigations have identified associations between elevated branched-chain amino acids (BCAAs) levels and an increased incidence of hypertensive disorders of pregnancy (HDP). The aim of this study is to rigorously explore the causal linkage between BCAAs concentrations and the risk of developing HDP. A bidirectional Mendelian randomization (MR) analysis was conducted to ascertain the causal relationship between BCAAs levels and the risk of HDP. Instrumental genetic variables derived from the genome-wide association studies of serum BCAAs levels – encompassing total BCAAs, leucine, isoleucine and valine from the UK Biobank, and HDP data (16,417 cases and 213,893 controls) from the FinnGen consortium – were utilized. We conducted inverse-variance weighted, MR-Egger, simple mode, and weighted MR estimates. To assess the heterogeneity and potential presence of horizontal pleiotropy among the instrumental variables, Cochran Q statistic and the MR-Egger intercept were employed. Simultaneously, transcriptomic data were utilized in conjunction with machine learning to identify key genes through which BCAAs influence HDP. Single-cell techniques were employed to analyze the major cell populations. The forward MR analysis indicated a significant positive correlation between the levels of total BCAAs (OR: 1.300, 95% CI: 1.117–1.462; P < .0001), leucine (OR: 1.096, 95% CI: 1.123–1.505; P < .0001), and valine (OR: 1.299, 95% CI: 1.141–1.478; P < .0001) with the risk of HDP. Isoleucine levels (OR: 1.266, 95% CI: 1.054–1.521; P = .012) demonstrated a positive association with HDP risk that did not reach statistical significance after Bonferroni correction. The reverse analysis revealed no causal effect of HDP on the levels of total BCAAs (OR: 0.992, 95% CI: 0.967–1.018; P = .543), leucine (OR: 1.005, 95% CI: 0.973–1.039; P = .750), isoleucine (OR: 1.000, 95% CI: 0.974–1.026; P = .973), and valine (OR: 0.988, 95% CI: 0.962–1.014; P = .354). Transcriptomic analysis identified MCCC2 and BCAT2 as key genes through which BCAAs affect the occurrence of HDP, and these genes are predominantly expressed in endothelial cells. We provide robust evidence Our findings suggest that HDP was associated with an increased level of BCAAs, and the effects may be related to the expression levels of MCCC2 and BCAT2 in endothelial cells.
- Open Access
- 20 November 2025
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1008, 178361
Betulinic acid and apoptosis-involved pathways: Unveiling its bidirectional regulatory role
- 20 November 2025
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1008, 178361
Open AccessBetulinic acid and apoptosis-involved pathways: Unveiling its bidirectional regulatory role
- Open Access
- 26 March 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (4) , 2081-2095
Elucidating the Molecular Mechanisms of Hederagenin-Regulated Mitophagy in Cervical Cancer SiHa Cells through an Integrative Approach Combining Proteomics and Advanced Network Association Algorithm
Hederagenin (Hed), a natural triterpenoid, exhibits antitumor potential in cervical cancer. The present study was designed to explore Hed's regulatory mechanisms on mitophagy in SiHa cervical cancer cells, employing tandem mass tag (TMT) proteomics and an advanced network association algorithm (NAA). Our findings revealed that Hed decreased SiHa cell viability, induced apoptosis, and altered mitochondrial membrane potential. Notably, Hed inhibited mitophagic flux under both normoxic and hypoxic conditions. Through TMT proteomics analysis and innovative NAA, we identified a close association between the HIF-1 signaling pathway and mitophagy. Network analysis further suggested that Hed acts on a target network centered on SRC, STAT3, AKT1, and HIF1A. Western blot analysis confirmed the expression and phosphorylation status of these targets in response to Hed. This study elucidates the molecular mechanisms underlying Hed's regulation of mitophagy in SiHa cells, offering novel insights and potential therapeutic targets for cervical cancer treatment.
- 26 March 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (4) , 2081-2095
Open AccessElucidating the Molecular Mechanisms of Hederagenin-Regulated Mitophagy in Cervical Cancer SiHa Cells through an Integrative Approach Combining Proteomics and Advanced Network Association Algorithm
Hederagenin (Hed), a natural triterpenoid, exhibits antitumor potential in cervical cancer. The present study was designed to explore Hed's regulatory mechanisms on mitophagy in SiHa cervical cancer cells, employing tandem mass tag (TMT) proteomics and an advanced network association algorithm (NAA). Our findings revealed that Hed decreased SiHa cell viability, induced apoptosis, and altered mitochondrial membrane potential. Notably, Hed inhibited mitophagic flux under both normoxic and hypoxic conditions. Through TMT proteomics analysis and innovative NAA, we identified a close association between the HIF-1 signaling pathway and mitophagy. Network analysis further suggested that Hed acts on a target network centered on SRC, STAT3, AKT1, and HIF1A. Western blot analysis confirmed the expression and phosphorylation status of these targets in response to Hed. This study elucidates the molecular mechanisms underlying Hed's regulation of mitophagy in SiHa cells, offering novel insights and potential therapeutic targets for cervical cancer treatment.
- 1 August 2022
- Published by Bentham Science Publishers Ltd. in Current Computer-Aided Drug Design
- Vol. 18 (5) , 347-362
Methodological Verification-based Screening of the Representative Ingredients for Traditional Chinese Medicine: Taking Astragalus as an Example for Interfering with Cervical Cancer
Background: The screening of effective ingredients is the bridge between the research of efficacy and the mechanism of traditional Chinese medicine. Although promising virtual screening has emerged as an attractive alternative, an ideal strategy is still urgently required due to the characteristics of multi-ingredients and multi-targets of traditional Chinese medicine.Objective: The aim of the study was to develop a methodological verification-based novel screening strategy capable of comprehensively assessing the ability of compounds to perturb disease networks, thereby identifying representative ingredients of traditional Chinese medicine interventions in complex diseases.Methods: In this article, we take astragalus interfering with cervical cancer as an example. First, a multifunctional clustering disease network model was constructed; second, the several drugs and their decoys were used for molecular docking with disease network clusters for methodological verification and determining the best scoring criteria. Third, the representative ingredients of astragalus were screened according to the best scoring criteria. Finally, the effects of the representative ingredients on cervical cancer SiHa cells were evaluated by CCK-8 assay, flow cytometry, and western blot analysis.Results: Three representative ingredients of astragalus were betulinic acid, hederagenin and methylnissolin, which perturbed the apoptosis, stabilization of p53, and G1/S transition cluster as a whole, respectively. CCK-8 assay showed that the IC50 value of betulinic acid, hederagenin and methylnissolin at 48 h was 28.84, 101.90, and 187.40 μM, respectively. Flow cytometry showed that these three representative ingredients could significantly induce early apoptosis and cell cycle arrest. Western blot analysis showed that betulinic acid treatment significantly increased p53 expression, while hederagenin and methylnissolin did not.Conclusions: This study has provided new ideas for the screening of effective ingredients in traditional Chinese medicine, and established a foundation for elucidating the overall mechanism of action of traditional Chinese medicine
- 1 August 2022
- Published by Bentham Science Publishers Ltd. in Current Computer-Aided Drug Design
- Vol. 18 (5) , 347-362
Methodological Verification-based Screening of the Representative Ingredients for Traditional Chinese Medicine: Taking Astragalus as an Example for Interfering with Cervical Cancer
Background: The screening of effective ingredients is the bridge between the research of efficacy and the mechanism of traditional Chinese medicine. Although promising virtual screening has emerged as an attractive alternative, an ideal strategy is still urgently required due to the characteristics of multi-ingredients and multi-targets of traditional Chinese medicine.Objective: The aim of the study was to develop a methodological verification-based novel screening strategy capable of comprehensively assessing the ability of compounds to perturb disease networks, thereby identifying representative ingredients of traditional Chinese medicine interventions in complex diseases.Methods: In this article, we take astragalus interfering with cervical cancer as an example. First, a multifunctional clustering disease network model was constructed; second, the several drugs and their decoys were used for molecular docking with disease network clusters for methodological verification and determining the best scoring criteria. Third, the representative ingredients of astragalus were screened according to the best scoring criteria. Finally, the effects of the representative ingredients on cervical cancer SiHa cells were evaluated by CCK-8 assay, flow cytometry, and western blot analysis.Results: Three representative ingredients of astragalus were betulinic acid, hederagenin and methylnissolin, which perturbed the apoptosis, stabilization of p53, and G1/S transition cluster as a whole, respectively. CCK-8 assay showed that the IC50 value of betulinic acid, hederagenin and methylnissolin at 48 h was 28.84, 101.90, and 187.40 μM, respectively. Flow cytometry showed that these three representative ingredients could significantly induce early apoptosis and cell cycle arrest. Western blot analysis showed that betulinic acid treatment significantly increased p53 expression, while hederagenin and methylnissolin did not.Conclusions: This study has provided new ideas for the screening of effective ingredients in traditional Chinese medicine, and established a foundation for elucidating the overall mechanism of action of traditional Chinese medicine
- Open Access
- 21 July 2022
- Published by SAGE Publications in Natural Product Communications
- Vol. 17 (7)
Target Identification-Based Analysis of Mechanism of Betulinic Acid-Induced Cells Apoptosis of Cervical Cancer SiHa
Cervical cancer is the fourth most common female malignancy with high morbidity and mortality, which urgently needs novel anti-cancer drugs. Accumulating investigations have focused on the antitumor activity of betulinic acid (BA), which is a natural compound with low toxicity and high efficiency. Although the effect of BA on SiHa cells is obvious, the specific mechanism is seldom studied. Target identification is an important part of research on the internal mechanism of action. In this current study, an integrated method based on literature collection, target prediction, enrichment analysis, network analysis, and western blotting experiments was performed to identify the potential key targets of BA-induced apoptosis. Then, combined with the identified potential key targets, the specific mechanism of BA-induced cervical cancer SiHa cells apoptosis was elucidated. Our present study demonstrated that BA significantly reduces the viability of cervical cancer SiHa cells in a dose- and time-dependent manner. In addition, 8 potential key targets (AKT1, CASP8, LMNA, TNF, BCL2, CASP3, PARP1, and XIAP) were obtained through our integrated target identification method. Meanwhile, western blotting showed that within a certain concentration range, the expression of cleaved-caspase 3, cleaved-PARP, and cytochrome c increased with the BA concentration, while XIAP was almost unchanged. Therefore, the effect of BA on cervical cancer is noticeable. BA-induced SiHa cells apoptosis is a multi-molecule coordinated process. In this process, BA is not only a participant in either the extrinsic or intrinsic pathways, but also a regulator of apoptosis effector molecules of the CASP3/PARP1 axis.
- 21 July 2022
- Published by SAGE Publications in Natural Product Communications
- Vol. 17 (7)
Open AccessTarget Identification-Based Analysis of Mechanism of Betulinic Acid-Induced Cells Apoptosis of Cervical Cancer SiHa
Cervical cancer is the fourth most common female malignancy with high morbidity and mortality, which urgently needs novel anti-cancer drugs. Accumulating investigations have focused on the antitumor activity of betulinic acid (BA), which is a natural compound with low toxicity and high efficiency. Although the effect of BA on SiHa cells is obvious, the specific mechanism is seldom studied. Target identification is an important part of research on the internal mechanism of action. In this current study, an integrated method based on literature collection, target prediction, enrichment analysis, network analysis, and western blotting experiments was performed to identify the potential key targets of BA-induced apoptosis. Then, combined with the identified potential key targets, the specific mechanism of BA-induced cervical cancer SiHa cells apoptosis was elucidated. Our present study demonstrated that BA significantly reduces the viability of cervical cancer SiHa cells in a dose- and time-dependent manner. In addition, 8 potential key targets (AKT1, CASP8, LMNA, TNF, BCL2, CASP3, PARP1, and XIAP) were obtained through our integrated target identification method. Meanwhile, western blotting showed that within a certain concentration range, the expression of cleaved-caspase 3, cleaved-PARP, and cytochrome c increased with the BA concentration, while XIAP was almost unchanged. Therefore, the effect of BA on cervical cancer is noticeable. BA-induced SiHa cells apoptosis is a multi-molecule coordinated process. In this process, BA is not only a participant in either the extrinsic or intrinsic pathways, but also a regulator of apoptosis effector molecules of the CASP3/PARP1 axis.
- 1 October 2020
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 261, 113106
Quantitative and network pharmacology: A case study of rhein alleviating pathological progress of renal interstitial fibrosis
- 1 October 2020
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 261, 113106
Quantitative and network pharmacology: A case study of rhein alleviating pathological progress of renal interstitial fibrosis
- Open Access
- 4 April 2016
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 54 (7) , 1166-1170
A Simple and Rapid UPLC Method for the Determination of Rosavin in Rat Plasma and Its Application to a Pharmacokinetic Study
Rosavin is a bioactive antidepressant component isolated from Rhodiola rosea L. In this work, an ultra-performance liquid chromatography (UPLC) method was established for the determination of rosavin in rat plasma. The chromatographic separation was achieved on a HSS T3 column (100 mm × 2.1 mm, 1.8 μm) with a gradient mobile phase consisting of acetonitrile and water (0.1% formic acid). Plasma samples were processed with one-step protein precipitation. Rutin was chosen as internal standard and the detection wavelength was 249 nm. The pharmacokinetic parameters were analyzed using the drug and statistics software. The results showed that the established method has an excellent linearity in the range of 10–1,000 ng/mL (R2 = 0.992) with a lower limit of quantification (10 ng/mL). The intra- and interday precision (relative standard deviation) were from 2.0 to 10.6% and the extraction recovery was 92.4–95.1%. The simple and rapid UPLC method was successfully applied to the pharmacokinetic and bioavailability study of rosavin in rats.
- 4 April 2016
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 54 (7) , 1166-1170
Open AccessA Simple and Rapid UPLC Method for the Determination of Rosavin in Rat Plasma and Its Application to a Pharmacokinetic Study
Rosavin is a bioactive antidepressant component isolated from Rhodiola rosea L. In this work, an ultra-performance liquid chromatography (UPLC) method was established for the determination of rosavin in rat plasma. The chromatographic separation was achieved on a HSS T3 column (100 mm × 2.1 mm, 1.8 μm) with a gradient mobile phase consisting of acetonitrile and water (0.1% formic acid). Plasma samples were processed with one-step protein precipitation. Rutin was chosen as internal standard and the detection wavelength was 249 nm. The pharmacokinetic parameters were analyzed using the drug and statistics software. The results showed that the established method has an excellent linearity in the range of 10–1,000 ng/mL (R2 = 0.992) with a lower limit of quantification (10 ng/mL). The intra- and interday precision (relative standard deviation) were from 2.0 to 10.6% and the extraction recovery was 92.4–95.1%. The simple and rapid UPLC method was successfully applied to the pharmacokinetic and bioavailability study of rosavin in rats.
- 12 February 2016
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 408 (10) , 2607-2619
The study on serum and urine of renal interstitial fibrosis rats induced by unilateral ureteral obstruction based on metabonomics and network analysis methods
Abstract Transmission of biological information is a biochemical process of multistep cascade from genes/proteins to metabolites. However, because most metabolites reflect the terminal information of the biochemical process, it is difficult to describe the transmission process of disease information in terms of the metabolomics strategy. In this paper, by incorporating network and metabolomics methods, an integrated approach was proposed to systematically investigate and explain the molecular mechanism of renal interstitial fibrosis. Through analysis of the network, the cascade transmission process of disease information starting from genes/proteins to metabolites was putatively identified and uncovered. The results indicated that renal fibrosis was involved in metabolic pathways of glycerophospholipid metabolism, biosynthesis of unsaturated fatty acids and arachidonic acid metabolism, riboflavin metabolism, tyrosine metabolism, and sphingolipid metabolism. These pathways involve kidney disease genes such as TGF-β1 and P2RX7. Our results showed that combining metabolomics and network analysis can provide new strategies and ideas for the interpretation of pathogenesis of disease with full consideration of “gene-protein-metabolite.” ᅟ
- 12 February 2016
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 408 (10) , 2607-2619
The study on serum and urine of renal interstitial fibrosis rats induced by unilateral ureteral obstruction based on metabonomics and network analysis methods
Abstract Transmission of biological information is a biochemical process of multistep cascade from genes/proteins to metabolites. However, because most metabolites reflect the terminal information of the biochemical process, it is difficult to describe the transmission process of disease information in terms of the metabolomics strategy. In this paper, by incorporating network and metabolomics methods, an integrated approach was proposed to systematically investigate and explain the molecular mechanism of renal interstitial fibrosis. Through analysis of the network, the cascade transmission process of disease information starting from genes/proteins to metabolites was putatively identified and uncovered. The results indicated that renal fibrosis was involved in metabolic pathways of glycerophospholipid metabolism, biosynthesis of unsaturated fatty acids and arachidonic acid metabolism, riboflavin metabolism, tyrosine metabolism, and sphingolipid metabolism. These pathways involve kidney disease genes such as TGF-β1 and P2RX7. Our results showed that combining metabolomics and network analysis can provide new strategies and ideas for the interpretation of pathogenesis of disease with full consideration of “gene-protein-metabolite.” ᅟ